Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice

被引:0
|
作者
Li, Hui [1 ]
Fang, Yujiao [1 ,2 ]
Wang, Da [1 ,2 ]
Shi, Bowen [1 ,2 ]
Thompson, Garth J. [1 ]
机构
[1] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源
NUTRITION & DIABETES | 2024年 / 14卷 / 01期
基金
中国国家自然科学基金;
关键词
RESTING-STATE FMRI; REDUCES FOOD-INTAKE; FUNCTIONAL CONNECTIVITY; GLOBAL SIGNAL; F-18-FDG PET; IN-VIVO; GLP-1; MRI; DIAGNOSIS;
D O I
10.1038/s41387-024-00343-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Quantitative mapping of the brain's metabolism is a critical tool in studying and diagnosing many conditions, from obesity to neurodegenerative diseases. In particular, noninvasive approaches are urgently required. Recently, there have been promising drug development approaches for the treatment of disorders related to glucose metabolism in the brain and, therefore, against obesity-associated diseases. One of the most important drug targets to emerge has been the Glucagon-like peptide-1 (GLP-1) and its receptor (GLP-1R). GLP and GLP-1R play an important role in regulating blood sugar and maintaining energy homeostasis. However, the macroscopic effects on brain metabolism and function due to the presence of GLP-1R are unclear. Methods To explore the physiological role of GLP-1R in mouse brain glucose metabolism, and its relationship to brain function, we used three methods. We used deuterium magnetic resonance spectroscopy (DMRS) to provide quantitative information about metabolic flux, fluorodeoxyglucose positron emission tomography (FDG-PET) to measure brain glucose metabolism, and resting state-functional MRI (rs-fMRI) to measure brain functional connectivity. We used these methods in both mice with complete GLP-1R knockout (GLP-1R KO) and wild-type C57BL/6N (WT) mice. Results The metabolic rate of GLP-1R KO mice was significantly slower than that of WT mice (p = 0.0345, WT mice 0.02335 +/- 0.057 mM/min, GLP-1R KO mice 0.01998 +/- 0.07 mM/min). Quantification of the mean [18F]FDG signal in the whole brain also showed significantly reduced glucose uptake in GLP-1R KO mice versus control mice (p = 0.0314). Observing rs-fMRI, the functional brain connectivity in GLP-1R KO mice was significantly lower than that in the WT group (p = 0.0032 for gFCD, p = 0.0002 for whole-brain correlation, p < 0.0001 for ALFF). Conclusions GLP-1R KO mice exhibit impaired brain glucose metabolism to high doses of exogenous glucose, and they also have reduced functional connectivity. This suggests that the GLP-1R KO mouse model may serve as a model for correlated metabolic and functional connectivity loss.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 receptor
    Krashes, Michael
    CURRENT BIOLOGY, 2024, 34 (23) : R1163 - R1164
  • [2] Renal effects of glucagon-like peptide-1 receptor knockout in Akita-diabetic mice
    Song, Panai
    Fu, Yiling
    Qiu, Hongyu
    Onishi, Akira
    Drucker, Daniel J.
    Vallon, Volker
    FASEB JOURNAL, 2016, 30
  • [3] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [4] Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited
    Jan Hansen
    Birgitte Brock
    Hans Erik Bøtker
    Albert Gjedde
    Jørgen Rungby
    Michael Gejl
    Reviews in Endocrine and Metabolic Disorders, 2014, 15 : 219 - 231
  • [5] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [6] Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited
    Hansen, Jan
    Brock, Birgitte
    Botker, Hans Erik
    Gjedde, Albert
    Rungby, Jorgen
    Gejl, Michael
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (03): : 219 - 231
  • [7] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [8] The effects of brain glucagon-like peptide-1 on peripheral glucose homeostasis
    Jessen, L.
    Greer, T. M.
    Iacono, M. E.
    Ellis, K. S.
    Paxton, B. M.
    Sandoval, D. A.
    Seeley, R. J.
    D'Alessio, D. A.
    DIABETOLOGIA, 2010, 53 : S15 - S16
  • [9] Sirt3 Regulates Glucose Metabolism in Mice through Glucagon-Like Peptide-1
    Uto, Asuka
    Miyashita, Kazutoshi
    Sato, Masaaki
    Endo, Sho
    Fujii, Chikako
    Mitsuishi, Masanori
    Ito, Hiroshi
    DIABETES, 2017, 66 : A530 - A530
  • [10] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730